NCT00492700View on ClinicalTrials.gov

A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2003

Conditions

Non Alcoholic Steatohepatitis

Interventions

DRUG

rosiglitazone

Trial Locations (1)

75013

Service d'hépatogastroenérologie, Hôpital Pitié Salpêtrière, Paris

All Listed Sponsors

lead

Association pour la Recherche sur les Maladies Hépatiques Virales

OTHER

NCT00492700 - A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis | Biotech Hunter | Biotech Hunter